City
Epaper

Reliance Capital fails to pay Rs 534 cr interest on EPFO’s NCD investment of Rs 2,500 cr

By Lokmat English Desk | Updated: December 15, 2021 10:37 IST

Anil Ambani's Reliance Capital Ltd (RCL) has defaulted payment of interest of Rs 534.64 crore on non-convertible debentures (NCD) ...

Open in App

Anil Ambani's Reliance Capital Ltd (RCL) has defaulted payment of interest of Rs 534.64 crore on non-convertible debentures (NCD) in which Employees Provident Fund Organisation (EPFO) had invested Rs 2,500 crore.

Employees Provident Fund Organisation (EPFO) has invested Rs 2,500 crore in Reliance Capital's bond programmes, for which RCL has defaulted in payment of interest from October 2019. 

EPFO had asked the government to initiate insolvency and bankruptcy proceedings against RCL. 

The Reserve Bank of India (RBI) has superseded RCL's board of directors on November 29, 2011. RBI on December 2, 2021 filed application for initiation of corporate insolvency resolution process (CIRP) against RCL.  Reliance Capital started facing tough times after it's Infrastructure Leasing & Financial Services (IL&FS) collapsed in September 2018.  

Tags: Reliance CapitalAnil AmbaniEmployees Provident Fund OrganizationReserve Bank Of India
Open in App

Related Stories

BusinessED Makes First Arrest in Rs 3,000-Crore Anil Ambani Loan Fraud Case

BusinessED Initiates Fresh Probe into Anil Ambani Group In Fake Bank Guarantee Racket

BusinessReliance Power, Reliance Infra Shares Crash After ED Summons Anil Ambani in Loan Fraud Case

MumbaiED Summons Industrialist Anil Ambani in Rs 3,000-Crore Bank Loan Fraud Case

BusinessReliance Power, Reliance Infra Shares Surge by 4% After ED Raids Conclude on Anil Ambani’s Reliance Group

Business Realted Stories

BusinessBe cautious with huge education loans as AI transforms jobs: Sridhar Vembu

BusinessWhy should you invest in the Bajaj Finserv Equity Savings Fund?

BusinessWoxsen University Claims Its Spot Among India's Best Universities in Outlook-ICARE Rankings 2025

Business1GV, Rx Propellant's Flagship Life Sciences Campus in Genome Valley, Hyderabad, Receives IFC EDGE Advanced Certification

BusinessSCDL's 25-Year Journey - Silver Jubilee Celebrations Across India